(+)-ALPHA-(2,3-DIMETHOXYPHENYL)-1-(2-(4-FLUOROPHENYL)ETHYL)-4-PIPERIDINEMETHANOL ODER PRODRUG DAVON ZUR BEHANDLUNG VON DEMENZSYMPTOMEN ODER KOGNITIVEN STÖRUNGEN

European patent · EP1289527 · Deleted

Register entry

Publication number
EP1289527
Application number
EP01939312
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 23, 2001
Published
Mar 12, 2003
Granted
Mar 26, 2008
Deleted
May 31, 2010
Reason
Annual fee unpaid
IPC classes
A61K 31/445 (2006.01)
Priority
US 206943 P 25.05.2000
PCT application
PCT/US2001/016653 23.05.2001
PCT publication
WO2001/089498 29.11.2001
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 22, 2010

    Deleted, fee unpaid

    Published in Swissreg on 22.12.2010

  2. May 28, 2010

    Transferred

    Owner
    Aventis Pharmaceuticals Inc., 300 Somerset Corporate Boulevard, Bridgewater, New Jersey 08807, USA → HMR Pharma, Inc., 3711 Kennett Pike, Suite 200, Greenville, Delaware 19807, USA

    Published in Swissreg on 28.05.2010

  3. May 28, 2010

    Transferred

    Owner
    HMR Pharma, Inc., 3711 Kennett Pike, Suite 200, Greenville, Delaware 19807, USA → Aventis Holdings Inc., 3711 Kennett Pike, Suite 200, Greenville, Delaware 19807, USA

    Published in Swissreg on 28.05.2010

  4. May 27, 2010

    Agent entered

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in Swissreg on 27.05.2010

  5. Apr 30, 2008

    Granted

    Published in +pat+ No 8 in 2008

Parties

Inventor

SCHEYER, Richard

Branchburg Township, NJ 07008, US

SORENSEN, Stephen

Chester, NJ 07930, US

HITCHCOCK, Janice

Fishers, IN 46038, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.